Identification |
Name: | 6,14-Ethenomorphinan-7-methanol,17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-a,a-dimethyl-, (5a,7a)- |
Synonyms: | 6,14-endo-Ethanotetrahydrooripavine,21-cyclopropyl-7a-(1-hydroxy-1-methylethyl)-(8CI);1-N-Cyclopropylmethyl-6,7,8,14-tetrahydro-6,14-endoethano-7-(2'-hydroxy-2'-propyl)nororipavine;Diprenorphine; M 5050; M 5050 Injection;N-(Cyclopropylmethyl)-19-methylnororvinol; RX 5050M |
CAS: | 14357-78-9 |
EINECS: | 238-325-7 |
Molecular Formula: | C26H35 N O4 |
Molecular Weight: | 425.5604 |
InChI: | InChI=1/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | 1.33 g/cm3 |
Refractive index: | 1.656 |
Biological Activity: | Non-selective opioid receptor antagonist (K i values are 0.017, 0.072 and 0.23 nM for κ -, μ - and δ -opioid receptors). |
Flash Point: | °C |
Safety Data |
Hazard Symbols |
Xn: Harmful
|
|
|